Dosing Guide

Prescribing information is available at the bottom of this page.

Please click here to view the downloadable Dosing Guide.

Formulations and Strengths1

CRESEMBA® Formulations and Strengths

References

  1. CRESEMBA Summary of Product Characteristics.

Recommended dose1

CRESEMBA® Recommended Dose

References

  1. CRESEMBA Summary of Product Characteristics.

Dose adjustments1

  • No dose adjustment is necessary for:

    -   Patients with renal impairment (including patients with end-stage renal disease)

    -   Patients with mild or moderate hepatic impairment (Child-Pugh classes A and B). CRESEMBA has not been studied in patients with severe hepatic impairment (Child-Pugh class C). Use in these patients is not recommended unless the potential benefit is considered to outweigh the risks.

    -   Elderly patients

References

  1. CRESEMBA Summary of Product Characteristics.

Prescribing Information

This includes legal category, basic NHS cost and a link to SPC. Please click each relevant SPC link to be directed to EMC website.

 
Cresemba® (isavuconazole)
Cresemba® 100mg hard capsules – SPC
Legal Category: POM. Basic NHS Cost:14 caps pack £599.28
Cresemba® 200mg powder for concentrate for solution for infusion – SPC
Legal Category: POM Basic NHS Cost: 1 vial pack £297.84

 

Vfend® (Voriconazole)
Vfend® 50mg filmed tablets – SPC
Legal Category: POM. Basic NHS Cost: 28 tabs £275.68
Vfend® 200mg filmed tablets – SPC
Legal Category: POM. Basic NHS Cost: 28 tabs £1102.74
Vfend® 200mg powder for solution for infusion – SPC
Legal Category: POM. Basic NHS Cost: 1 vial £77.14
Vfend® 40mg/ml Powder for oral suspension – SPC
Legal Category: POM Basic NHS Cost: 75ml £551.37

PP-CRB-GBR-0803.  October 2020